JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that further to its press release dated July 1, 2009, Teva and Ortho McNeil Janssen have agreed to cease shipments of generic versions of Ortho Tri-Cyclen® Lo, pending a preliminary injunction hearing in the related patent infringement case which is scheduled to begin on July 15, 2009 at 9:30 a.m.
